Neuroone Medical Technologies is trading at $1.17 (-10.00%), with no clearly identified company-specific announcement to explain the September 29 decline. - Its latest surfaced company news was a September 17 Southern California distribution agreement. - Broader risk-off conditions may be weighing on shares: Reuters reported consumer confidence fell to 81.9, its lowest level since 2014; market coverage also cited elevated yields and inflation concerns. - Healthcare fell 1.33%, while broader indices were down less than 0.5%; a direct catalyst for the sharp move remains unconfirmed.